A randomized, double-blind trial comparing the effect of fluticasone/salmeterol 250/50 to salmeterol on COPD exacerbations in patients with COPD

被引：0
|
作者：
Ferguson, Gary [1 ]
Anzueto, Antonio [1 ]
Fei, Richard [1 ]
Emmett, Amanda [1 ]
Crater, Glenn [1 ]
Knobil, Kate [1 ]
Kalberg, Chris [1 ]
机构：
[1] Pulm Res Inst SE Michigan, Livonia, MI USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：530S / 531S
页数：2
相关论文
共 50 条
  • [41] Salmeterol combined with fluticasone propionate improved COPD in patients during stable stage
    Lu, Dongmei
    Ma, Junpeng
    Yang, Xiaohong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (09): : 2907 - 2911
  • [42] Effect Of Tiotropium And Salmeterol In COPD Patients With Low Or High Risk Of Exacerbations: A Post-Hoc Analysis From The Poet-COPD® Trial
    Vogelmeier, C.
    Asijee, G.
    Kupas, K.
    Beeh, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [43] Salmeterol & Fluticasone 50 μg/250 μg bid in combination provides a better long-term control than salmeterol 50 μg bid alone and placebo in COPD patients already treated with theophylline
    Dal Negro, RW
    Pomari, C
    Tognella, S
    Micheletto, C
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2003, 16 (04) : 241 - 246
  • [44] Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
    Wedzicha, Jadwiga A.
    Zhong, Nanshan
    Ichinose, Masakazu
    Humphries, Michael
    Fogel, Robert
    Thach, Chau
    Patalano, Francesco
    Banerji, Donald
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 339 - 349
  • [45] Effect Of Azithromycin Maintenance Treatment In Patients With Frequent Exacerbations Of COPD (columbus): A Randomized, Double-Blind, Placebo-Controlled Trial
    Uzun, S.
    Djamm, R. S.
    Mulder, P. G. H.
    Kluytmans, J. A. J. W.
    Pelle, A. J.
    Van 't Veer, N. E.
    Ermens, A. A. M.
    Pelle, A. J.
    Hoogsteden, H. C.
    Aerts, J. G. J. V.
    Van der Eerden, M. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [46] Influence of salmeterol/fluticasone via single versus separate inhalers on exacerbations in severe/very severe COPD
    Hagedorn, Cordula
    Kaessner, Frank
    Banik, Norbert
    Ntampakas, Paris
    Fielder, Karin
    RESPIRATORY MEDICINE, 2013, 107 (04) : 542 - 549
  • [47] Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study
    Ilowite, J
    Webb, R
    Friedman, B
    Kerwin, E
    Bird, SR
    Hustad, CM
    Edelman, JM
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2004, 92 (06) : 641 - 648
  • [48] Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD®
    Claus F. Vogelmeier
    Guus M. Asijee
    Katrin Kupas
    Kai M. Beeh
    Advances in Therapy, 2015, 32 : 537 - 547
  • [49] Tiotropium and Salmeterol in COPD Patients at Risk of Exacerbations: A Post Hoc Analysis from POET-COPD®
    Vogelmeier, Claus F.
    Asijee, Guus M.
    Kupas, Katrin
    Beeh, Kai M.
    ADVANCES IN THERAPY, 2015, 32 (06) : 537 - 547
  • [50] Association of β2-adrenoreceptor genotypes with prevention of COPD exacerbations by tiotropium or salmeterol in the POET-COPD® trial
    Koegler, Harald
    Rabe, Klaus F.
    Beeh, Kai M.
    Glaab, Thomas
    Schmidt, Hendrik
    Fabbri, Leonardo M.
    Vogelmeier, Claus
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345